Skip to main content
Top
Published in: Inflammopharmacology 4/2020

01-08-2020 | Joint Pain | Original Article

Hesperidin methyl chalcone interacts with NFκB Ser276 and inhibits zymosan-induced joint pain and inflammation, and RAW 264.7 macrophage activation

Authors: Fernanda S. Rasquel-Oliveira, Marilia F. Manchope, Larissa Staurengo-Ferrari, Camila R. Ferraz, Telma Saraiva-Santos, Tiago H. Zaninelli, Victor Fattori, Nayara A. Artero, Stephanie Badaro-Garcia, Andressa de Freitas, Rubia Casagrande, Waldiceu A. Verri Jr.

Published in: Inflammopharmacology | Issue 4/2020

Login to get access

Abstract

Arthritis can be defined as a painful musculoskeletal disorder that affects the joints. Hesperidin methyl chalcone (HMC) is a flavonoid with analgesic, anti-inflammatory, and antioxidant effects. However, its effects on a specific cell type and in the zymosan-induced inflammation are unknown. We aimed at evaluating the effects of HMC in a zymosan-induced arthritis model. A dose–response curve of HMC (10, 30, or 100 mg/kg) was performed to determine the most effective analgesic dose after intra-articular zymosan stimuli. Knee joint oedema was determined using a calliper. Leukocyte recruitment was performed by cell counting on knee joint wash as well as histopathological analysis. Oxidative stress was measured by colorimetric assays (GSH, FRAP, ABTS and NBT) and RT-qPCR (gp91phox and HO-1 mRNA expression) performed. In vitro, oxidative stress was assessed by DCFDA assay using RAW 264.7 macrophages. Cytokine production was evaluated in vivo and in vitro by ELISA. In vitro NF-κB activation was analysed by immunofluorescence. We observed HMC reduced mechanical hypersensitivity and knee joint oedema, leukocyte recruitment, and pro-inflammatory cytokine levels. We also observed a reduction in zymosan-induced oxidative stress as per increase in total antioxidant capacity and reduction in gp91phox and increase in HO-1 mRNA expression. Accordingly, total ROS production and macrophage NFκB activation were diminished. HMC interaction with NFκB p65 at Ser276 was revealed using molecular docking analysis. Thus, data presented in this work suggest the usefulness of HMC as an analgesic and anti-inflammatory in a zymosan-induced arthritis model, possibly by targeting NFκB activation in macrophages.
Literature
go back to reference Aguilar Peralta GR, Arévalo Gardoqui J, Llamas Macías FJ et al (2007) Clinical and capillaroscopic evaluation in the treatment of chronic venous insufficiency with Ruscus aculeatus, hesperidin methylchalcone and ascorbic acid in venous insufficiency treatment of ambulatory patients. Int Angiol 26:378–384PubMed Aguilar Peralta GR, Arévalo Gardoqui J, Llamas Macías FJ et al (2007) Clinical and capillaroscopic evaluation in the treatment of chronic venous insufficiency with Ruscus aculeatus, hesperidin methylchalcone and ascorbic acid in venous insufficiency treatment of ambulatory patients. Int Angiol 26:378–384PubMed
go back to reference Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4:499–511CrossRef Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4:499–511CrossRef
go back to reference Beukelman T, Callahan L, Choi H, et al (2017) Arthritis by the numbers—book of trusted facts & figures, 1.2. Arthritis Foundation Beukelman T, Callahan L, Choi H, et al (2017) Arthritis by the numbers—book of trusted facts & figures, 1.2. Arthritis Foundation
go back to reference Cannon GW, Openshaw SJ, Hibbs JB Jr et al (1996) Nitric oxide production during adjuvant-induced and collagen-induced arthritis. Arthritis Rheumatol 39:1677–1684CrossRef Cannon GW, Openshaw SJ, Hibbs JB Jr et al (1996) Nitric oxide production during adjuvant-induced and collagen-induced arthritis. Arthritis Rheumatol 39:1677–1684CrossRef
go back to reference Harris ED (1991) Pathogenesis of rheumatoid arthritis: its relevance to therapy in the’90 s. Trans Am Clin Climatol Assoc 102:260–268 discussion 268–70 PubMedPubMedCentral Harris ED (1991) Pathogenesis of rheumatoid arthritis: its relevance to therapy in the’90 s. Trans Am Clin Climatol Assoc 102:260–268 discussion 268–70 PubMedPubMedCentral
go back to reference Ismail Simsek MD (2011) TNF inhibitors for rheumatoid arthritis. Bull NHU Hosp Jt Dis 69:220–224 Ismail Simsek MD (2011) TNF inhibitors for rheumatoid arthritis. Bull NHU Hosp Jt Dis 69:220–224
go back to reference Kim GW, Lee NR, Pi RH et al (2015) IL-6 inhibitors for treatment of rheumatoid arthritis: past, present, and future. Arch Pharm Res 38:575–584CrossRef Kim GW, Lee NR, Pi RH et al (2015) IL-6 inhibitors for treatment of rheumatoid arthritis: past, present, and future. Arch Pharm Res 38:575–584CrossRef
go back to reference Maioli NA, Zarpelon AC, Mizokami SS et al (2015) The superoxide anion donor, potassium superoxide, induces pain and inflammation in mice through production of reactive oxygen species and cyclooxygenase-2. Brazilian J Med Biol Res Rev Bras Pesqui medicas e Biol 48:321–331. https://doi.org/10.1590/1414-431x20144187 CrossRef Maioli NA, Zarpelon AC, Mizokami SS et al (2015) The superoxide anion donor, potassium superoxide, induces pain and inflammation in mice through production of reactive oxygen species and cyclooxygenase-2. Brazilian J Med Biol Res Rev Bras Pesqui medicas e Biol 48:321–331. https://​doi.​org/​10.​1590/​1414-431x20144187 CrossRef
go back to reference Mirshafiey A, Mohsenzadegan M (2008) The role of reactive oxygen species in immunopathogenesis of rheumatoid arthritis. Iran J Allergy Asthma Immunol 7:195–202PubMed Mirshafiey A, Mohsenzadegan M (2008) The role of reactive oxygen species in immunopathogenesis of rheumatoid arthritis. Iran J Allergy Asthma Immunol 7:195–202PubMed
go back to reference Verri WA, Vicentini FTMC, Baracat MM et al (2012) Flavonoids as anti-inflammatory and analgesic drugs: mechanisms of action and perspectives in the development of pharmaceutical forms. In: Studies in natural products chemistry. pp 297–330 Verri WA, Vicentini FTMC, Baracat MM et al (2012) Flavonoids as anti-inflammatory and analgesic drugs: mechanisms of action and perspectives in the development of pharmaceutical forms. In: Studies in natural products chemistry. pp 297–330
Metadata
Title
Hesperidin methyl chalcone interacts with NFκB Ser276 and inhibits zymosan-induced joint pain and inflammation, and RAW 264.7 macrophage activation
Authors
Fernanda S. Rasquel-Oliveira
Marilia F. Manchope
Larissa Staurengo-Ferrari
Camila R. Ferraz
Telma Saraiva-Santos
Tiago H. Zaninelli
Victor Fattori
Nayara A. Artero
Stephanie Badaro-Garcia
Andressa de Freitas
Rubia Casagrande
Waldiceu A. Verri Jr.
Publication date
01-08-2020
Publisher
Springer International Publishing
Published in
Inflammopharmacology / Issue 4/2020
Print ISSN: 0925-4692
Electronic ISSN: 1568-5608
DOI
https://doi.org/10.1007/s10787-020-00686-7

Other articles of this Issue 4/2020

Inflammopharmacology 4/2020 Go to the issue